Delaware
|
000-25426
|
74-1871327
|
||
(State or other jurisdiction of incorporation)
|
(Commission File Number)
|
(IRS Employer
Identification No.)
|
|
[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Exhibit No.
|
Description
|
|
99.1
|
Press Release dated January 28, 2016
|
|
NATIONAL INSTRUMENTS CORPORATION
|
|||
By:
|
/s/ DAVID G. HUGLEY
|
||
David G. Hugley
Vice President & General Counsel; Secretary
|
●
|
Record revenue of $334 million, up 0.5 percent year over year in U.S. dollar terms with core revenue up 4.3 percent year over year
|
|
●
|
Record bookings for software
|
|
●
|
GAAP operating margin of 15 percent
|
|
●
|
Non-GAAP operating margin of 18.5 percent
|
|
●
|
Fully diluted GAAP EPS of $0.25 and fully diluted non-GAAP EPS of $0.34
|
|
●
|
EBITDA of $63 million or $0.49 per share
|
|
●
|
Cash and short-term investments of $333 million as of Dec. 31, 2015
|
●
|
Revenue of $1.23 billion, down 1.5 percent year over year
|
|
●
|
Core revenue up 6 percent year-over-year
|
|
●
|
Fully diluted GAAP EPS of $0.74
|
|
●
|
Non-GAAP fully diluted EPS of $1.00
|
|
●
|
EBITDA of $204 million, or $1.59 per share
|
|
●
|
Dividends paid of $98 million, or $0.76 per share
|
National Instruments
|
||||||||
Condensed Consolidated Balance Sheets
|
||||||||
(in thousands, unaudited)
|
||||||||
December 31,
|
December 31,
|
|||||||
2015
|
2014
|
|||||||
Assets
|
||||||||
Current assets:
|
||||||||
Cash and cash equivalents
|
251,129 | 274,030 | ||||||
Short-term investments
|
81,789 | 197,163 | ||||||
Accounts receivable, net
|
216,244 | 202,329 | ||||||
Inventories, net
|
185,197 | 173,052 | ||||||
Prepaid expenses and other current assets
|
65,381 | 70,075 | ||||||
Deferred income taxes, net
|
- | 31,171 | ||||||
Total current assets
|
799,740 | 947,820 | ||||||
Property and equipment, net
|
257,853 | 264,086 | ||||||
Goodwill
|
257,718 | 144,325 | ||||||
Intangible assets, net
|
108,196 | 78,282 | ||||||
Other long-term assets
|
30,349 | 20,978 | ||||||
Total assets
|
1,453,856 | 1,455,491 | ||||||
Liabilities and Stockholders' Equity
|
||||||||
Current liabilities:
|
||||||||
Accounts payable
|
50,970 | 58,603 | ||||||
Accrued compensation
|
27,956 | 33,774 | ||||||
Deferred revenue - current
|
112,283 | 105,964 | ||||||
Accrued expenses and other liabilities
|
11,755 | 14,714 | ||||||
Other taxes payable
|
37,250 | 34,602 | ||||||
Total current liabilities
|
240,214 | 247,657 | ||||||
Long-term debt
|
37,000 | - | ||||||
Deferred income taxes
|
44,673 | 47,406 | ||||||
Liability for uncertain tax positions
|
11,974 | 10,127 | ||||||
Deferred revenue - long-term
|
27,708 | 26,452 | ||||||
Other long-term liabilities
|
10,565 | 6,353 | ||||||
Total liabilities
|
372,134 | 337,995 | ||||||
Stockholders' equity:
|
||||||||
Preferred stock
|
- | - | ||||||
Common stock
|
1,275 | 1,278 | ||||||
Additional paid-in capital
|
717,706 | 662,889 | ||||||
Retained earnings
|
400,831 | 464,993 | ||||||
Accumulated other comprehensive income (loss)
|
(38,090) | (11,664) | ||||||
Total stockholders' equity
|
1,081,722 | 1,117,496 | ||||||
Total liabilities and stockholders' equity
|
1,453,856 | 1,455,491 |
National Instruments
|
|||||||||
Condensed Consolidated Statements of Income
|
|||||||||
(in thousands, except per share data, unaudited)
|
|||||||||
Three Months Ended
|
Year Ended
|
||||||||
December 31,
|
December 31,
|
||||||||
2015
|
2014
|
2015
|
2014
|
||||||
Net sales:
|
|||||||||
Product
|
$
|
306,350
|
$
|
305,176
|
$
|
1,113,590
|
$
|
1,143,000
|
|
Software maintenance
|
27,989
|
27,600
|
111,866
|
100,862
|
|||||
Total net sales
|
334,339
|
332,776
|
1,225,456
|
1,243,862
|
|||||
Cost of sales:
|
|||||||||
Product
|
85,575
|
83,094
|
311,226
|
312,623
|
|||||
Software maintenance
|
1,200
|
1,066
|
5,730
|
5,509
|
|||||
Total cost of sales
|
86,775
|
84,160
|
316,956
|
318,132
|
|||||
Gross profit
|
247,564
|
248,616
|
908,500
|
925,730
|
|||||
74.0%
|
74.7%
|
74.1%
|
74.4%
|
||||||
Operating expenses:
|
|||||||||
Sales and marketing
|
116,348
|
113,819
|
452,263
|
461,845
|
|||||
Research and development
|
56,670
|
57,351
|
225,131
|
227,433
|
|||||
General and administrative
|
24,544
|
22,411
|
93,935
|
91,265
|
|||||
Total operating expenses
|
197,562
|
193,581
|
771,329
|
780,543
|
|||||
Operating income
|
50,002
|
55,035
|
137,171
|
145,187
|
|||||
Other income (expense):
|
|||||||||
Interest income
|
314
|
340
|
1,403
|
1,133
|
|||||
Net foreign exchange loss
|
(5,110)
|
(1,245)
|
(7,075)
|
(2,250)
|
|||||
Other (expense) income, net
|
(1,014)
|
(352)
|
(221)
|
(69)
|
|||||
Income before income taxes
|
44,192
|
53,778
|
131,278
|
144,001
|
|||||
Provision for income taxes
|
12,058
|
10,393
|
36,016
|
17,668
|
|||||
Net income
|
$
|
32,134
|
$
|
43,385
|
$
|
95,262
|
$
|
126,333
|
|
Basic earnings per share
|
$
|
0.25
|
$
|
0.34
|
$
|
0.74
|
$
|
0.99
|
|
Diluted earnings per share
|
$
|
0.25
|
$
|
0.34
|
$
|
0.74
|
$
|
0.99
|
|
Weighted average shares outstanding -
|
|||||||||
basic
|
127,341
|
127,755
|
127,997
|
127,030
|
|||||
diluted
|
127,798
|
128,233
|
128,668
|
127,799
|
|||||
Dividends declared per share
|
$
|
0.19
|
$
|
0.15
|
$
|
0.76
|
$
|
0.60
|
National Instruments
|
|||||
Condensed Consolidated Statements of Cash Flows
|
|||||
(in thousands, unaudited)
|
|||||
2015
|
2014
|
||||
Cash flow from operating activities:
|
|||||
Net income
|
$
|
95,262
|
126,333
|
||
Adjustments to reconcile net income to net cash provided by operating activities:
|
|||||
Depreciation and amortization
|
74,090
|
70,206
|
|||
Stock-based compensation
|
24,572
|
25,759
|
|||
Tax expense/(benefit) expense from deferred income taxes
|
9,361
|
5,886
|
|||
Tax benefit from stock option plans
|
(967)
|
(1,242)
|
|||
Net change in operating assets and liabilities
|
(39,586)
|
(31,836)
|
|||
Net cash provided by operating activities
|
162,732
|
195,106
|
|||
Cash flow from investing activities:
|
|||||
Capital expenditures
|
(33,984)
|
(44,944)
|
|||
Capitalization of internally developed software
|
(31,356)
|
(25,781)
|
|||
Additions to other intangibles
|
(2,811)
|
(2,834)
|
|||
Acquisitions, net of cash received
|
(125,710)
|
-
|
|||
Purchases of short-term investments
|
(29,649)
|
(123,849)
|
|||
Sales and maturities of short-term investments
|
145,023
|
89,835
|
|||
Net cash used by investing activities
|
(78,487)
|
(107,573)
|
|||
Cash flow from financing activities:
|
|||||
Proceeds from revolving line of credit
|
54,000
|
-
|
|||
Principal payments on revolving line of credit
|
(17,000)
|
-
|
|||
Proceeds from issuance of common stock
|
27,785
|
31,277
|
|||
Repurchase of common stock
|
(75,255)
|
-
|
|||
Dividends paid
|
(97,643)
|
(76,285)
|
|||
Tax benefit from stock option plans
|
967
|
1,242
|
|||
Net cash used by financing activities
|
(107,146)
|
(43,766)
|
|||
Net change in cash and cash equivalents
|
(22,901)
|
43,767
|
|||
Cash and cash equivalents at beginning of period
|
274,030
|
230,263
|
|||
Cash and cash equivalents at end of period
|
$
|
251,129
|
274,030
|
Detail of GAAP charges related to stock-based compensation, amortization of acquisition intangibles, acquisition related transaction costs, restructuring charges, foreign exchange loss on acquisitions and impairment of minority cost basis investments (unaudited)
|
||||||||
Three Months Ended
|
Year Ended
|
|||||||
December 31,
|
December 31,
|
|||||||
2015
|
2014
|
2015
|
2014
|
|||||
Stock-based compensation
|
||||||||
Cost of sales
|
$
|
509
|
$
|
447
|
$
|
1,936
|
$
|
1,711
|
Sales and marketing
|
2,701
|
2,597
|
11,003
|
10,931
|
||||
Research and development
|
2,240
|
2,428
|
9,004
|
9,649
|
||||
General and administrative
|
888
|
810
|
3,544
|
3,467
|
||||
Provision for income taxes
|
(1,870)
|
(1,497)
|
(7,289)
|
(7,414)
|
||||
Total
|
$
|
4,468
|
$
|
4,785
|
$
|
18,198
|
$
|
18,344
|
Amortization of acquisition intangibles
|
||||||||
Cost of sales
|
$
|
3,080
|
$
|
2,660
|
$
|
10,938
|
$
|
10,651
|
Sales and marketing
|
740
|
433
|
2,039
|
1,784
|
||||
Research and development
|
316
|
369
|
1,299
|
1,567
|
||||
Other income, net
|
93
|
165
|
542
|
672
|
||||
Provision for income taxes
|
(1,398)
|
(1,199)
|
(4,867)
|
(4,846)
|
||||
Total
|
$
|
2,831
|
$
|
2,428
|
$
|
9,951
|
$
|
9,828
|
Acquisition transaction costs, restructuring charges, and other
|
||||||||
Cost of sales
|
$
|
296
|
$
|
742
|
$
|
1,269
|
$
|
1,289
|
Sales and marketing
|
123
|
37
|
123
|
189
|
||||
Research and development
|
198
|
178
|
198
|
442
|
||||
General and administrative
|
593
|
96
|
1,035
|
241
|
||||
Foreign exchange loss on acquisition
|
3,111
|
-
|
3,111
|
-
|
||||
Impairment of minority cost basis investment
|
1,000
|
-
|
1,000
|
-
|
||||
Provision for income taxes
|
(1,453)
|
(286)
|
(1,843)
|
(674)
|
||||
$
|
3,868
|
$
|
767
|
$
|
4,893
|
$
|
1,487
|
|
Reconciliation of Gross Profit to Non-GAAP Gross Profit
|
|||||||||
Three Months Ended
|
Year Ended
|
||||||||
December 31,
|
December 31,
|
||||||||
2015
|
2014
|
2015
|
2014
|
||||||
Gross profit, as reported
|
$
|
247,564
|
$
|
248,616
|
$
|
908,500
|
$
|
925,730
|
|
Stock-based compensation
|
509
|
447
|
1,936
|
1,711
|
|||||
Amortization of acquisition intangibles
|
3,080
|
2,660
|
10,938
|
10,651
|
|||||
Acquisition transaction costs, restructuring charges and other
|
296
|
742
|
1,269
|
1,289
|
|||||
Non-GAAP gross profit
|
$
|
251,449
|
$
|
252,465
|
$
|
922,643
|
$
|
939,381
|
|
Non-GAAP gross margin
|
75.2%
|
75.9%
|
75.3%
|
75.5%
|
|||||
Reconciliation of Operating Expenses to Non-GAAP Operating Expenses
|
|||||||||
Three Months Ended
|
Year Ended
|
||||||||
December 31,
|
December 31,
|
||||||||
2015
|
2014
|
2015
|
2014
|
||||||
Operating expenses, as reported
|
$
|
197,562
|
$
|
193,581
|
$
|
771,329
|
$
|
780,543
|
|
Stock-based compensation
|
(5,829)
|
(5,835)
|
(23,551)
|
(24,047)
|
|||||
Amortization of acquisition intangibles
|
(1,056)
|
(802)
|
(3,338)
|
(3,351)
|
|||||
Acquisition transaction costs, restructuring charges and other
|
(914)
|
(311)
|
(1,356)
|
(872)
|
|||||
Non-GAAP operating expenses
|
$
|
189,763
|
$
|
186,633
|
$
|
743,084
|
$
|
752,273
|
|
Reconciliation of Operating Income to Non-GAAP Operating Income
|
|||||||||
Three Months Ended
|
Year Ended
|
||||||||
December 31,
|
December 31,
|
||||||||
2015
|
2014
|
2015
|
2014
|
||||||
Operating income, as reported
|
$
|
50,002
|
$
|
55,035
|
$
|
137,171
|
$
|
145,187
|
|
Stock-based compensation
|
6,338
|
6,282
|
25,487
|
25,758
|
|||||
Amortization of acquisition intangibles
|
4,136
|
3,462
|
14,276
|
14,002
|
|||||
Acquisition transaction costs, restructuring charges and other
|
1,210
|
1,053
|
2,625
|
2,161
|
|||||
Non-GAAP operating income
|
$
|
61,686
|
$
|
65,832
|
$
|
179,559
|
$
|
187,108
|
|
Non-GAAP operating margin
|
18.5%
|
19.8%
|
14.7%
|
15.0%
|
|||||
Reconciliation of Income before income taxes to Non-GAAP Income before income taxes
|
|||||||||
Three Months Ended
|
Year Ended
|
||||||||
December 31,
|
December 31,
|
||||||||
2015
|
2014
|
2015
|
2014
|
||||||
Income before income taxes, as reported
|
$
|
44,192
|
$
|
53,778
|
$
|
131,278
|
$
|
144,001
|
|
Stock-based compensation
|
6,338
|
6,282
|
25,487
|
25,758
|
|||||
Amortization of acquisition intangibles
|
4,229
|
3,627
|
14,818
|
14,674
|
|||||
Acquisition transaction costs, restructuring charges and other
|
5,321
|
1,053
|
6,736
|
2,161
|
|||||
Non-GAAP income before income taxes
|
$
|
60,080
|
$
|
64,740
|
$
|
178,319
|
$
|
186,594
|
|
Reconciliation of Provision for income taxes to Non-GAAP Provision for income taxes
|
|||||||||
Three Months Ended
|
Year Ended
|
||||||||
December 31,
|
December 31,
|
||||||||
2015
|
2014
|
2015
|
2014
|
||||||
Provision for income taxes, as reported
|
$
|
12,058
|
$
|
10,393
|
$
|
36,016
|
$
|
17,668
|
|
Stock-based compensation
|
1,870
|
1,497
|
7,289
|
7,414
|
|||||
Amortization of acquisition intangibles
|
1,398
|
1,199
|
4,867
|
4,846
|
|||||
Acquisition transaction costs, restructuring charges and other
|
1,453
|
286
|
1,843
|
674
|
|||||
Non-GAAP provision for income taxes
|
$
|
16,779
|
$
|
13,375
|
$
|
50,015
|
$
|
30,602
|
|
Reconciliation of GAAP Net Income, Basic EPS and Diluted EPS to Non-GAAP Net Income, Non-GAAP Basic EPS and Non-GAAP Diluted EPS (unaudited)
|
||||||||||
Three Months Ended
|
Year Ended
|
|||||||||
December 31,
|
December 31,
|
|||||||||
2015
|
2014
|
2015
|
2014
|
|||||||
Net income, as reported
|
$
|
32,134
|
$
|
43,385
|
$
|
95,262
|
$
|
126,333
|
||
Adjustments to reconcile net income to non-GAAP net income:
|
||||||||||
Stock-based compensation, net of tax effect
|
4,468
|
4,785
|
18,198
|
18,344
|
||||||
Amortization of acquisition intangibles, net of tax effect
|
2,831
|
2,428
|
9,951
|
9,828
|
||||||
Acquisition transaction costs, restructuring charges and other, net of tax effect
|
3,868
|
767
|
4,893
|
1,487
|
||||||
Non-GAAP net income
|
$
|
43,301
|
$
|
51,365
|
$
|
128,304
|
$
|
155,992
|
||
Basic EPS, as reported
|
$
|
0.25
|
$
|
0.34
|
$
|
0.74
|
$
|
0.99
|
||
Adjustment to reconcile basic EPS to non-GAAP basis EPS:
|
||||||||||
Impact of stock-based compensation, net of tax effect
|
0.04
|
0.04
|
0.14
|
0.14
|
||||||
Impact of amortization of acquisition intangibles, net of tax effect
|
0.02
|
0.02
|
0.08
|
0.08
|
||||||
Impact of acquisition transaction costs, restructuring charges and other, net of tax effect
|
0.03
|
-
|
0.04
|
0.02
|
||||||
Non-GAAP basic EPS
|
$
|
0.34
|
$
|
0.40
|
$
|
1.00
|
$
|
1.23
|
||
Diluted EPS, as reported
|
$
|
0.25
|
$
|
0.34
|
$
|
0.74
|
$
|
0.99
|
||
Adjustment to reconcile diluted EPS to non-GAAP diluted EPS:
|
||||||||||
Impact of stock-based compensation, net of tax effect
|
0.04
|
0.04
|
0.14
|
0.14
|
||||||
Impact of amortization of acquisition intangibles, net of tax effect
|
0.02
|
0.02
|
0.08
|
0.08
|
||||||
Impact of acquisition transaction costs, restructuring charges and other, net of tax effect
|
0.03
|
-
|
0.04
|
0.01
|
||||||
Non-GAAP diluted EPS
|
$
|
0.34
|
$
|
0.40
|
$
|
1.00
|
$
|
1.22
|
||
Weighted average shares outstanding -
|
||||||||||
Basic
|
127,341
|
127,755
|
127,997
|
127,030
|
||||||
Diluted
|
127,798
|
128,233
|
128,668
|
127,799
|
||||||
Reconciliation of Net Income and Diluted EPS to EBITDA and EBITDA Diluted EPS
|
||||||||
(unaudited)
|
||||||||
Three Months Ended
|
Year Ended
|
|||||||
December 31,
|
December 31,
|
|||||||
2015
|
2014
|
2015
|
2014
|
|||||
Net income, as reported
|
$
|
32,134
|
$
|
43,385
|
$
|
95,262
|
$
|
126,333
|
Adjustments to reconcile net income to EBITDA:
|
||||||||
Interest income, net of interest expense
|
(167)
|
(306)
|
(1,099)
|
(991)
|
||||
Tax expense
|
12,058
|
10,393
|
36,016
|
17,668
|
||||
Depreciation and amortization
|
18,933
|
19,195
|
74,090
|
70,206
|
||||
EBITDA
|
$
|
62,958
|
$
|
72,667
|
$
|
204,269
|
$
|
213,216
|
Diluted EPS, as reported
|
$
|
0.25
|
$
|
0.34
|
$
|
0.74
|
$
|
0.99
|
Adjustment to reconcile diluted EPS to EBITDA
|
||||||||
Interest income, net of interest expense
|
-
|
-
|
(0.01)
|
(0.01)
|
||||
Taxes
|
0.09
|
0.08
|
0.28
|
0.14
|
||||
Depreciation and amortization
|
0.15
|
0.15
|
0.58
|
0.55
|
||||
EBITDA diluted EPS
|
$
|
0.49
|
$
|
0.57
|
$
|
1.59
|
$
|
1.67
|
Weighted average shares outstanding - Diluted
|
127,798
|
128,233
|
128,668
|
127,799
|
Reconciliation of GAAP to Non-GAAP EPS Guidance
|
||||
(unaudited)
|
||||
Three Months Ended
|
||||
March 31, 2016
|
||||
Low
|
High
|
|||
GAAP Fully Diluted EPS, guidance
|
$
|
0.09
|
$
|
0.21
|
Adjustment to reconcile diluted EPS to non-GAAP diluted EPS:
|
||||
Impact of stock-based compensation, net of tax effect
|
0.04
|
0.04
|
||
Impact of amortization of acquisition intangibles, net of tax effect
|
0.03
|
0.03
|
||
Impact of acquisition restructuring costs, net of tax effect
|
0.01
|
0.01
|
||
Non-GAAP diluted EPS, guidance
|
$
|
0.17
|
$
|
0.29
|
National Instruments
|
|||
Reconciliation of GAAP Revenue to Core Revenue
|
|||
(unaudited)
|
|||
Three Months Ended
|
|||
December 31,
|
|||
2015
|
|||
YoY GAAP revenue growth, as reported
|
$
|
0.5%
|
|
Effect of excluding our current largest customer
|
-0.7%
|
||
YoY GAAP revenue growth, excluding our largest customer
|
-0.2%
|
||
Effect of excluding the impact of foreign currency exchange
|
4.5%
|
||
YoY Core revenue growth
|
$
|
4.3%
|
|
National Instruments
|
|||
Reconciliation of GAAP Revenue to Core Revenue
|
|||
(unaudited)
|
|||
Year Ended
|
|||
December 31,
|
|||
2015
|
|||
YoY GAAP revenue growth, as reported
|
$
|
-1.5%
|
|
Effect of excluding our current largest customer
|
1.8%
|
||
YoY GAAP revenue growth, excluding our largest customer
|
.3%
|
||
Effect of excluding the impact of foreign currency exchange
|
5.8%
|
||
YoY Core revenue growth
|
$
|
6.1%
|
|
National Instruments
|
|||
Reconciliation of GAAP Revenue to Core Revenue Guidance
|
|||
(unaudited)
|
|||
Three Months Ended
|
|||
March 31,
|
|||
2016
|
|||
Estimated YoY GAAP revenue growth, as reported
|
$
|
5.3%
|
|
Estimated effect of excluding our current largest customer
|
-0.3%
|
||
Estimated YoY GAAP revenue growth, excluding our largest customer
|
5.0%
|
||
Estimated effect of excluding the impact of foreign currency exchange
|
4.0%
|
||
Estimated YoY Core revenue growth
|
$
|
9.0%
|
|